Patent Assignment
Reel/Frame 012656/0599
Assignment of Assignor's Interest
Recorded: 2002-02-19
Pages: 2
Assignee
SYN X PHARMA
6354 VISCOUNT ROAD, MISSISSAUGA, ONTARIO L4V 1H3, CANADA
Covered Property
(1)
Fibronectin Biopolymer Markers Indicative of Type Ii Diabetes
Application:
09/991,796 →
Publication:
US 2003/0100010
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest
Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Change of Name
Nov 10, 2006
From: SYN X PHARMA INC.
To: NANOGEN POINT CARE, INC.
Reel/Frame 018516/0995 →
Assignment of Assignor's Interest
Nov 13, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018521/0373 →
Assignment of Intellectual Property Security Agreement
Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest
Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest
Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →